Literature DB >> 21851406

Should teriparatide ever be used for adynamic bone disease?

Daniel Cejka1, Martin Haas.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21851406     DOI: 10.1111/j.1525-139X.2011.00911.x

Source DB:  PubMed          Journal:  Semin Dial        ISSN: 0894-0959            Impact factor:   3.455


× No keyword cloud information.
  2 in total

Review 1.  Prevention and treatment of bone changes associated with exposure to glucocorticoids.

Authors:  Amy H Warriner; Kenneth G Saag
Journal:  Curr Osteoporos Rep       Date:  2013-12       Impact factor: 5.096

2.  Treatment of adynamic bone disease in a haemodialysis patient with teriparatide.

Authors:  Panagiotis Giamalis; Dominiki Economidou; Chrysostomos Dimitriadis; Dimitrios Memmos; Aikaterini Papagianni; Georgios Efstratiadis
Journal:  Clin Kidney J       Date:  2015-02-10
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.